Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms N-(4-Methoxy-13C-phenyl)acetamide |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Failure, Acute | Phase 3 | US | 10 Jun 2016 | |
Liver Failure, Acute | Phase 3 | US | 10 Jun 2016 | |
Pulmonary Disease, Chronic Obstructive | Phase 3 | IL | 30 Sep 2010 | |
Hepatitis B, Chronic | Phase 3 | IL | 17 Sep 2010 | |
liver function failure | Phase 3 | IL | 31 Mar 2010 | |
liver function failure | Phase 3 | US | 31 Mar 2010 | |
Fibrosis | Phase 3 | US | 31 Aug 2008 | |
Fibrosis | Phase 2 | US | 31 Aug 2008 | |
Fibrosis | Phase 2 | IL | 31 Aug 2008 | |
Fibrosis | Phase 2 | IL | 31 Aug 2008 |
Phase 2/3 | 76 | qpsfwhdzhu(bvegvdkorm) = xxysciwknb elbqamstke (hnadhgajia, rgneifqojg - tzyzeijenu) View more | - | 22 Dec 2020 | |||
Not Applicable | 15 | 13C-methacetin | nqukdnslhd(kuocmjxqkl) = azpbehvapu zrjbgpodtl (fuvfnqrpyf, 753 - 61) | - | 27 Aug 2020 |